Amedeo Smart

Free Medical Literature Service

 

Amedeo

Lung Cancer
  Free Subscription

04.05.2026

1 AJR Am J Roentgenol
1 Am J Respir Cell Mol Biol
1 Ann Oncol
1 Ann Surg Oncol
2 Ann Thorac Surg
5 Anticancer Res
1 Arch Bronconeumol
1 Arch Pathol Lab Med
4 BMC Cancer
1 Br J Cancer
1 Cancer Lett
2 Cancer Sci
2 Clin Cancer Res
6 Clin Lung Cancer
1 J Cancer Res Clin Oncol
1 J Clin Invest
1 J Clin Oncol
2 J Thorac Oncol
1 JAMA Oncol
4 Lung Cancer
1 Oncogene
1 PLoS Comput Biol
4 PLoS One
1 Proc Natl Acad Sci U S A
1 Thorax


    AJR Am J Roentgenol

  1. ROSENKRANTZ AB
    April 2026: Screening DBT, Vision-Language Models, Lung Cancer Ablation, and More.
    AJR Am J Roentgenol. 2026 Apr 29:1-2. doi: 10.2214/AJR.25.33516.
    >> Share


    Am J Respir Cell Mol Biol

  2. GHANBAR MI, Villabona-Rueda A, Philip N, Rodriguez Ortega R, et al
    Macrophage CCL18 promotes lung inflammation in checkpoint inhibitor pneumonitis.
    Am J Respir Cell Mol Biol. 2026;74:454-465.
    >> Share


    Ann Oncol

  3. MAVRIKIOS A, Bortolot M, Le Pechoux C, Remon J, et al
    Lung cancer brain metastases management at the dawn of personalized medicine: are we ready to break the barriers?
    Ann Oncol. 2026 Apr 28:S0923-7534(26)00159-6. doi: 10.1016/j.annonc.2026.
    >> Share


    Ann Surg Oncol

  4. D'SOUZA M, Andree M, Feili A, Sadr-Azodi O, et al
    Pulmonary Metastases After Surgical Resection of Pancreatic Ductal Adenocarcinoma: Impact on Long-Term Survival and Perspectives on Targeted Treatments.
    Ann Surg Oncol. 2026 Apr 27. doi: 10.1245/s10434-026-19586.
    >> Share


    Ann Thorac Surg

  5. BOSTOCK IC, Fox AH, Engelhardt KE, Huang K, et al
    Does This Lymph Node Look Bulky to You? What Should We Do About It? A Survey of Thoracic Surgeons.
    Ann Thorac Surg. 2026;121:1195-1201.
    >> Share

  6. WATANABE Y, Uchida S, Hattori A, Fukui M, et al
    A Comparative Analysis of Nodal Spread in Solid-Predominant vs Pure-Solid Stage IA Hypometabolic Lung Adenocarcinoma.
    Ann Thorac Surg. 2026;121:1221-1229.
    >> Share


    Anticancer Res

  7. NAKATANI H, Kawachi H, Yamada T, Furuya N, et al
    Cancer Cachexia Predicts Benefit of Immunotherapy Plus Chemotherapy in EGFR-mutant NSCLC After TKI Resistance.
    Anticancer Res. 2026;46:2789-2806.
    >> Share

  8. HASHIMOTO K, Nishimura S, Goto K
    Potential of Inflammatory and Nutritional Markers and Clinicopathological Factors for Prognostic Prediction in Osteosarcoma.
    Anticancer Res. 2026;46:2713-2723.
    >> Share

  9. LAN D, Wei L, Liu D, Mao YA, et al
    NK92-exo Induces Ferroptosis in A549 Cells by Targeting a miR-663a-SLC11A2 Axis.
    Anticancer Res. 2026;46:2467-2485.
    >> Share

  10. NOJIRI T, Omura A, Nishimura H, Uda H, et al
    Life-threatening Pneumonitis Induced by Osimertinib Monotherapy as a First-line Treatment for Epidermal Growth Factor Receptor Mutation-positive Non-small-cell Lung Cancer: A Retrospective Case-series Study.
    Anticancer Res. 2026;46:2781-2788.
    >> Share

  11. GULDIMANN M, El-Gedaily M, Cimander B, Belde D, et al
    Effect of Increased Image Matrix on Lung Nodule Volumetry in Chest CT: A Phantom Study.
    Anticancer Res. 2026;46:2693-2702.
    >> Share


    Arch Bronconeumol

  12. CABALLEROS LAM M, Pujols Leon PR, Inarrairaegui M, Ezponda A, et al
    Comparison of Lung Cancer Screening Programs in Liver Transplant Recipients and the General Population.
    Arch Bronconeumol. 2026 Apr 9:S0300-2896(26)00124.
    >> Share


    Arch Pathol Lab Med

  13. LI J, Sandhu A, Smith M, Larsen BT, et al
    The Utility of CDX2 and CK20 Immunohistochemical Reactivity to Distinguish Adenocarcinomas of the Lung From Their Benign Mimics.
    Arch Pathol Lab Med. 2025;150:360-364.
    >> Share


    BMC Cancer

  14. YIN X, He X, Guo W, Lu H, et al
    Prognostic value of CALLY index in patients with locally advanced non-small cell lung cancer treated with thoracic radiotherapy.
    BMC Cancer. 2026 Apr 24. doi: 10.1186/s12885-026-16061.
    >> Share

  15. YAMAGUCHI T, Shimizu J, Matsuzawa R, Shimomura K, et al
    Five-year prognostic impact of pre-existing interstitial lung disease in non-small cell lung cancer patients treated with anti-PD-1 monotherapy: a retrospective analysis.
    BMC Cancer. 2026 Apr 25. doi: 10.1186/s12885-026-15989.
    >> Share

  16. ZHANG M, Jiao T, Ma Y, Yang S, et al
    The dual role of baseline absolute eosinophil count in non-small cell lung cancer immunotherapy: a biomarker for enhanced efficacy and elevated risk of immune checkpoint inhibitor-related pneumonitis.
    BMC Cancer. 2026 Apr 27. doi: 10.1186/s12885-026-16104.
    >> Share

  17. CHEN S, Yu J, Zhou Q, Li L, et al
    Trends in cardiovascular disease mortality among older adults with co-occuring lung cancer in the United States from 1999 to 2020.
    BMC Cancer. 2026 Apr 28. doi: 10.1186/s12885-026-16010.
    >> Share


    Br J Cancer

  18. CHOI E, Luo S, Ding VY, Graber-Nadich A, et al
    Air pollution and the risk of second primary lung cancer among lung cancer survivors: the prospective UK Biobank cohort study.
    Br J Cancer. 2026 Apr 27. doi: 10.1038/s41416-026-03454.
    >> Share


    Cancer Lett

  19. ZHANG D, Zhou L, Dai C, Peng J, et al
    Extracellular matrix stiffness orchestrates NETs formation and mTOR-Driven metabolic reprogramming in lung cancer.
    Cancer Lett. 2026;651:218537.
    >> Share


    Cancer Sci

  20. LIANG Y, Ma H, Sun W, Chen Y, et al
    The Overlooked Autoantibody Repertoire: Exploring the Biomarker Potential of Downregulated Autoantibodies in NSCLC.
    Cancer Sci. 2026;117:1244-1259.
    >> Share

  21. JIN Y, Zhang T, Wu Z, Liang Y, et al
    SMURF1 Regulates CTCF-HOXA10 Axis and Promotes Tumor Progression in Nasopharyngeal Carcinoma.
    Cancer Sci. 2026;117:1346-1361.
    >> Share


    Clin Cancer Res

  22. LEE EJ, Ko JA, Kim MJ, Cho JS, et al
    JIN-A02, a Mutant-Selective Fourth-Generation EGFR Inhibitor, Overcomes C797S-Mediated Resistance and Demonstrates Intracranial Activity in NSCLC.
    Clin Cancer Res. 2026;32:1835-1845.
    >> Share

  23. HASHMI A, Linford J, Chauhan PS, Parikh K, et al
    Early ctDNA stratifies survival in locally advanced and oligometastatic lung cancer treated with radiotherapy.
    Clin Cancer Res. 2026 Apr 30. doi: 10.1158/1078-0432.CCR-25-4983.
    >> Share


    Clin Lung Cancer

  24. CELIKARSLAN S, Sezen D, Duman M, Durankus NK, et al
    Real-World Clinical Outcomes of Concurrent Chemotherapy and Dose-Escalated Twice-Daily Radiotherapy With Simultaneous Integrated Boost (SIB) for Limited-Stage Small Cell Lung Cancer.
    Clin Lung Cancer. 2026 Mar 26:S1525-7304(26)00043.
    >> Share

  25. LO S, Li Y, Laden F, Kessler W, et al
    Neighborhood Socioeconomics and Lung Cancer Recurrence and Progression.
    Clin Lung Cancer. 2026 Mar 29:S1525-7304(26)00045.
    >> Share

  26. KUMAR P, Slaven JE, Zhou T, Tran M, et al
    Prognostic Significance and Biomarker Identification by Progression Patterns in Patients With Small Cell Lung Cancer After Immune Checkpoint Inhibitors.
    Clin Lung Cancer. 2026 Apr 3:S1525-7304(26)00048.
    >> Share

  27. LIU H, Gu Z, Yu K, Zhao ZR, et al
    Adjuvant Therapy After Pathologic Complete Response to Neoadjuvant Immunochemotherapy in Non-Small Cell Lung Cancer: A Multicenter Retrospective Real-World Study.
    Clin Lung Cancer. 2026 Apr 3:S1525-7304(26)00049.
    >> Share

  28. GHADDAR F, Ahmed S, Kirsch B, Jennewein L, et al
    Brief Report: A Pilot Study Evaluating the Feasibility, Safety, and Compliance With a Fasting-Mimicking Diet in Patients With Metastatic Non-Small Cell Lung Cancer.
    Clin Lung Cancer. 2026;27:24-28.
    >> Share

  29. KROPF-SANCHEN C, Frost N, Kuon J, Wermke M, et al
    A Retrospective, Multicenter Analysis Within the National Network Genomic Medicine Lung Cancer in Germany to Detect RET Fusions as a Possible Mechanism of Resistance in Patients With EGFR Mutations.
    Clin Lung Cancer. 2026 Mar 18:S1525-7304(26)00039.
    >> Share


    J Cancer Res Clin Oncol

  30. MAEDA R, Inomata M, Hazemoto T, Yamada R, et al
    Idiopathic pulmonary fibrosis predicts local recurrence following surgery in patients with non-small cell lung cancer.
    J Cancer Res Clin Oncol. 2026;152:95.
    >> Share


    J Clin Invest

  31. XING W, Zhou Y, Haedicke K, Wang C, et al
    Label-free streamlined photoacoustic image guidance facilitates NIR-II photoablation in models of melanoma lung metastases.
    J Clin Invest. 2026;136:e196095.
    >> Share


    J Clin Oncol

  32. SHIMIZU T, Sands J, Yoh K, Spira A, et al
    Erratum: First-In-Human, Phase I Dose-Escalation and Dose-Expansion Study of Trophoblast Cell-Surface Antigen 2-Directed Antibody-Drug Conjugate Datopotamab Deruxtecan in Non-Small-Cell Lung Cancer: TROPION-PanTumor01.
    J Clin Oncol. 2026 Apr 30:JCO2600937. doi: 10.1200/JCO-26-00937.
    >> Share


    J Thorac Oncol

  33. KOGA T, Ogawa H, Radulovich N, Pham NA, et al
    Endobronchial Ultrasound-Guided Biopsy Derived Lung Cancer Models: A Platform for Precision Therapy.
    J Thorac Oncol. 2026 Apr 27:103893. doi: 10.1016/j.jtho.2026.103893.
    >> Share

  34. HUANG J, Chen G, Wang Z, Jin W, et al
    Deulorlatinib (TGRX-326) in ALK gene fusion positive non-small cell lung cancer after failure of second-generation inhibitors (DRAGON): a single-arm, multicenter, phase 2 trial.
    J Thorac Oncol. 2026 Apr 22:103737. doi: 10.1016/j.jtho.2026.103737.
    >> Share


    JAMA Oncol

  35. SOCINSKI MA, Stahel R, Lee DH, Cappuzzo F, et al
    Tiragolumab Plus Atezolizumab and Chemotherapy for Advanced Nonsquamous Non-Small Cell Lung Cancer: The Phase 3 SKYSCRAPER-06 Randomized Clinical Trial.
    JAMA Oncol. 2026 Apr 30. doi: 10.1001/jamaoncol.2026.0818.
    >> Share


    Lung Cancer

  36. SAIKI M, Inoue T, Takusagawa K, Homma K, et al
    Association of tumor CD73 expression with clinical outcomes in small cell lung cancer treated with first-line chemo-immunotherapy.
    Lung Cancer. 2026;216:109425.
    >> Share

  37. ELTER T, Marschall U, Maier PM, Grellmann C, et al
    Real-world evidence of the impact of guideline concordance on survival in non-small cell lung cancer.
    Lung Cancer. 2026;216:109426.
    >> Share

  38. SOO RA, Fernandez-Penas P, Li M, Voon PJ, et al
    Asia-Pacific practical consensus in the management of adverse events related to amivantamab-based therapies in non-small cell lung cancer.
    Lung Cancer. 2026;216:109405.
    >> Share

  39. GALLAGHER TJ, Kokot NC, Lopez J, Rodriguez E, et al
    Association of cannabis use and lung cancer: a retrospective cohort study.
    Lung Cancer. 2026;216:109421.
    >> Share


    Oncogene

  40. LYU Q, Liu H, Shen W, Lin Z, et al
    KDM4B/DHX9 promotes chemoresistance in small-cell lung cancer through the MYCN-driven signaling pathway.
    Oncogene. 2026 Apr 29. doi: 10.1038/s41388-026-03798.
    >> Share


    PLoS Comput Biol

  41. ATITEY K, Anchang B
    PICDGI: A framework for predicting cancer driver genes through dynamic gene-gene interaction modeling of single-cell data.
    PLoS Comput Biol. 2026;22:e1014143.
    >> Share


    PLoS One

  42. RUANGPRACHA A, Sae-Lee C, Chitta P, Grove H, et al
    Unraveling the role of ChREBP in lung adenocarcinoma: Expression, regulatory networks, and potential functional impact.
    PLoS One. 2026;21:e0347907.
    >> Share


  43. Retraction: High CASC expression predicts poor prognosis of lung cancer: A systematic review with meta-analysis.
    PLoS One. 2026;21:e0348041.
    >> Share

  44. VAILANKANNI N, Nagarajan B
    Deep feature optimization using fusion of multiple self-supervised learning approaches and filter-based feature selection for lung cancer histopathology classification.
    PLoS One. 2026;21:e0348194.
    >> Share


  45. Retraction: Analysis of survival for lung cancer resections cases with fuzzy and soft set theory in surgical decision making.
    PLoS One. 2026;21:e0347910.
    >> Share


    Proc Natl Acad Sci U S A

  46. GARRIDO A, Tamayo-Torres E, Abdo S, Durham E, et al
    The antimetastatic effects of calorie restriction are negated by voluntary exercise in an aggressive breast cancer mouse model.
    Proc Natl Acad Sci U S A. 2026;123:e2524488123.
    >> Share


    Thorax

  47. MULLEN KA, Evison M
    Smoking cessation within lung cancer screening: how much more evidence is needed?
    Thorax. 2026 Apr 24:thorax-2026-224965. doi: 10.1136/thorax-2026-224965.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016